S5 HOLDINGS LLC AND MEDMEN ENTERPRISES INC. BOARD NOMINATION RIGHTS AGREEMENT DATED AS OF AUGUST 17, 2021 BOARD NOMINATION RIGHTS AGREEMENTBoard Nomination Rights Agreement • September 24th, 2021 • MedMen Enterprises, Inc. • Retail-retail stores, nec • British Columbia
NOW THEREFORE this agreement witnesses that in consideration of the respective covenants and agreements of the parties herein contained and for other good and valuable consideration (the receipt, sufficiency and adequacy of which is hereby acknowledged), the parties hereto agree as follows:
Gotham Green Partners, LLC AND Medmen enterprises inc. board nomination rights AGREEMENT DATED AS OF august 17, 2021 board nomination RIGHTS AGREEMENTBoard Nomination Rights Agreement • October 29th, 2021 • MedMen Enterprises, Inc. • Retail-retail stores, nec • British Columbia
RECITAL: In connection with the ongoing ownership as of the date hereof of certain securities of the Corporation by the GGP Funds (as defined herein), being certain limited partnerships in respect of which GGP is designated as the investment adviser, the parties hereto have agreed to enter into this agreement to grant certain rights which are set out herein to GGP, on the terms and subject to the conditions set out herein.
BlueLine PartnersBoard Nomination Rights Agreement • April 21st, 2017 • Iridex Corp • Electromedical & electrotherapeutic apparatus
This letter is to notify you that BlueLine is in the process of winding down and believes that interest will be best served by eliminating the various timing and information strictures created by the board service of BlueLine’s Primary Purchaser Director Designee.
December 9, 2015 BVF Partners L.P. One Sansome Street, 39th Floor San Francisco, CA 94104 Ladies and Gentlemen:Board Nomination Rights Agreement • December 9th, 2015 • Cti Biopharma Corp • Pharmaceutical preparations • New York
In exchange for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, each of CTI BioPharma Corp., a Washington corporation (the “Company”), and BVF Partners L.P. (“BVF” and, together with its affiliates, the “Shareholder”) agree as follows:
BOARD NOMINATION RIGHTS AGREEMENTBoard Nomination Rights Agreement • March 30th, 2021 • SOC Telemed, Inc. • Services-misc health & allied services, nec • Delaware
THIS BOARD NOMINATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of March 26, 2021 (the “Effective Time”), by and among SOC Telemed, Inc., a Delaware corporation (the “Company”), and Christopher Gallagher, M.D. (the “Designee”). Capitalized terms used but not otherwise defined in this Agreement have the respective meanings given to them in the Purchase Agreement (as defined below).
January 11, 2016 BVF Partners L.P. Biotechnology Value Fund, L.P. Biotechnology Value Fund II, L.P. BVF Inc. One Sansome Street, 30th Floor San Francisco, CA 94104 Biotechnology Value Trading Fund OS, L.P. BVF Partners OS Ltd. PO Box 309 Ugland House...Board Nomination Rights Agreement • January 11th, 2016 • Oncothyreon Inc. • Services-commercial physical & biological research • Delaware
In exchange for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Oncothyreon Inc., a Delaware corporation (the “Company”), and each of BVF Partners L.P. (“BVF”), Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P., Biotechnology Value Trading Fund OS, L.P., BVF Partners OS Ltd. and BVF Inc. (each, individually, a “Stockholder” and, collectively, the “Stockholders”), agree as follows:
